您的位置: 首页 > 农业专利 > 详情页

Intranasal administration
专利权人:
Optinose AS
发明人:
Djupesland, Per Gisle,Mahmoud, Ramy A,Andreassen, Ole A,Westlye, Lars T,Quintana, Daniel S,Smerud, Knut T,Sheldrake, Colin David
申请号:
AU2015348297
公开号:
AU2015348297A1
申请日:
2015.11.19
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
A delivery device for and method of modulating a condition relating to social cognition and/or behaviour in a human subject using oxytocin, non-peptide agonists thereof and/or antagonists thereof, comprising : providing a nosepiece to a first nasal cavity of the subject; and providing a supply unit for administering less than 241 U of oxytocin, non-peptide agonists thereof and/or antagonists thereof through the nosepiece to an upper region posterior of the nasal valve which is innervated by the trigeminal nerve.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充